- Home
- AQST vs NXRT Comparison
AQST vs NXRT Comparison
Compare AQST & NXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- NXRT
- Stock Information
- Founded
- AQST 2004
- NXRT 2014
- Country
- AQST United States
- NXRT United States
- Employees
- AQST N/A
- NXRT N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- NXRT Real Estate Investment Trusts
- Sector
- AQST Health Care
- NXRT Real Estate
- Exchange
- AQST Nasdaq
- NXRT Nasdaq
- Market Cap
- AQST 809.3M
- NXRT 776.2M
- IPO Year
- AQST 2018
- NXRT N/A
- Fundamental
- Price
- AQST $6.99
- NXRT $30.89
- Analyst Decision
- AQST Strong Buy
- NXRT Hold
- Analyst Count
- AQST 7
- NXRT 5
- Target Price
- AQST $10.71
- NXRT $37.33
- AVG Volume (30 Days)
- AQST 3.6M
- NXRT 156.2K
- Earning Date
- AQST 10-31-2025
- NXRT 10-28-2025
- Dividend Yield
- AQST N/A
- NXRT 6.56%
- EPS Growth
- AQST N/A
- NXRT N/A
- EPS
- AQST N/A
- NXRT N/A
- Revenue
- AQST $44,132,000.00
- NXRT $254,446,000.00
- Revenue This Year
- AQST N/A
- NXRT N/A
- Revenue Next Year
- AQST $51.50
- NXRT $3.72
- P/E Ratio
- AQST N/A
- NXRT N/A
- Revenue Growth
- AQST N/A
- NXRT N/A
- 52 Week Low
- AQST $2.12
- NXRT $29.98
- 52 Week High
- AQST $7.55
- NXRT $48.31
- Technical
- Relative Strength Index (RSI)
- AQST 63.34
- NXRT 42.35
- Support Level
- AQST $6.78
- NXRT $30.23
- Resistance Level
- AQST $7.55
- NXRT $32.02
- Average True Range (ATR)
- AQST 0.41
- NXRT 0.77
- MACD
- AQST 0.04
- NXRT -0.07
- Stochastic Oscillator
- AQST 71.13
- NXRT 33.08
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About NXRT NexPoint Residential Trust Inc.
NexPoint Residential Trust Inc is a real estate investment trust company. Its objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. The company seeks to achieve these objectives through targeted management and a capex value-add program. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.